Oasmia Pharmaceutical AB

(SSE:OASM; NASDAQ:OASM)

Collapse Summary General Information
 Location Uppsala, Sweden
 Region
 Country Sweden
 Business Category Drug delivery, Cancer, Veterinary
 Year Founded 1999
 Website http://www.oasmia.com
 Lead Product Status Market (drug)
Get a free BioCentury trial today
 Archive Items are loading loading
 Financial Information
 
 Earnings Summary
 Stocks Annual Chart
Week of 12/08/2017 - 1,993,116 Week of 12/01/2017 - 2,027,483 Week of 11/24/2017 - 1,735,472 Week of 11/17/2017 - 2,752,932 Week of 11/10/2017 - 4,420,486 Week of 11/03/2017 - 2,962,270 Week of 10/27/2017 - 4,397,580 Week of 10/20/2017 - 1,516,761 Week of 10/13/2017 - 1,590,830 Week of 10/06/2017 - 3,311,154 Week of 09/29/2017 - 2,051,881 Week of 09/22/2017 - 1,904,196 Week of 09/15/2017 - 6,035,367 Week of 09/08/2017 - 2,203,829 Week of 09/01/2017 - 1,872,771 Week of 08/25/2017 - 2,239,675 Week of 08/18/2017 - 2,520,488 Week of 08/11/2017 - 4,038,770 Week of 08/04/2017 - 4,740,275 Week of 07/28/2017 - 976,920 Week of 07/21/2017 - 960,430 Week of 07/14/2017 - 2,788,115 Week of 07/07/2017 - 2,867,843 Week of 06/30/2017 - 3,628,589 Week of 06/23/2017 - 7,727,563 Week of 06/16/2017 - 10,796,157 Week of 06/09/2017 - 8,845,862 Week of 06/02/2017 - 3,601,501 Week of 05/26/2017 - 1,671,396 Week of 05/19/2017 - 2,806,297 Week of 05/12/2017 - 5,275,859 Week of 05/05/2017 - 1,761,747 Week of 04/28/2017 - 2,401,276 Week of 04/21/2017 - 2,194,922 Week of 04/14/2017 - 2,091,378 Week of 04/07/2017 - 4,822,432 Week of 03/31/2017 - 2,622,225 Week of 03/24/2017 - 3,697,429 Week of 03/17/2017 - 2,751,649 Week of 03/10/2017 - 4,831,504 Week of 03/03/2017 - 24,613,351 Week of 02/24/2017 - 4,371,509 Week of 02/17/2017 - 1,654,797 Week of 02/10/2017 - 3,147,684 Week of 02/03/2017 - 2,645,408 Week of 01/27/2017 - 3,173,497 Week of 01/20/2017 - 6,006,968 Week of 01/13/2017 - 3,079,070 Week of 01/06/2017 - 1,926,509 Week of 12/30/2016 - 2,905,802 Week of 12/23/2016 - 2,180,959 Week of 12/16/2016 - 2,027,848 Week of 12/09/2016 - 246,465
 Pipeline Information
 
 Deals Information